MA

Healthcare · Pharmaceuticals

Mangalam Drugs and Organics Ltd (MANGALAM)

₹27.55

Mkt cap
₹46 Cr
P/E ratio
—
P/B
0.49
Div yield
0.00%
ROE
−34.80%
ROCE
−13.80%
EPS (TTM)
—
Book value
₹56
52W range
23–63
Sector
Healthcare

Price history

Previous close

Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates. [1]

NSE MANGALAMBSE 532637
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−55.92% from high
₹28
₹23+20.83% from low₹63
Current
₹27.55
Prev close
₹28.56
Day
−3.54%
Price performance
1D
−3.75%
1W
−5.95%
1M
−7.03%
3M
+2.00%
6M
−9.90%
1Y
−55.87%
YTD
−9.14%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales81.5697.34102.2476.5379.9488.7172.7857.2149.5458.3867.2957.1279.39
YoY Sales growth-24.71%+53.73%+12.22%-12.50%-1.99%-8.87%-28.81%-25.25%-38.03%-34.19%-7.54%-0.16%+60.25%
Expenses79.3790.3690.5468.3471.2579.9462.8861.8652.3759.9672.6556.2280.64
Operating Profit2.196.9811.708.198.698.779.90-4.65-2.83-1.58-5.360.90-1.25
OPM %2.69%7.17%11.44%10.70%10.87%9.89%13.60%-8.13%-5.71%-2.71%-7.97%1.58%-1.57%
Other Income0.030.000.050.020.140.130.470.140.030.220.090.110.17
Interest3.243.313.953.753.673.494.034.045.034.053.083.683.89
Depreciation3.733.623.863.873.973.934.614.384.534.374.563.994.02
Profit before tax-4.750.053.940.591.191.481.73-12.93-12.36-9.78-12.91-6.66-8.99
Tax %-25.05%-920.00%9.90%-355.93%-125.21%5.41%90.75%6.19%-41.42%0.00%1.16%13.36%-19.80%
Net Profit-3.560.503.552.682.691.400.15-13.73-7.25-9.78-13.06-7.55-7.21
EPS in Rs-2.250.322.241.691.700.880.09-8.67-4.58-6.18-8.25-4.77-4.56
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.05% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast12 Aug '26◦5 Nov '26◦
Earnings day+1.91%−6.01%
+1 day+2.93%−4.63%
+5 days−1.17%−6.66%
+15 days+11.11%—
+30 days+16.72%—
FilingPDFXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
35.65%Promoter
Promoters35.65%
FIIs0.11%
Public64.24%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Mangalam Drugs₹29.23—460.00%−7+0.55%79+60.25%−13.80%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings